Cardinal Health Inc.
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher after entering into bind...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. T...
Latest News
5 hours ago · zacks.com
Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?Cardinal Health CAH is scheduled to report first-quarter fiscal 2027 results on Nov. 5, before the market opens. The company entered the quarter with strong pharmaceutical demand, expanding specialty operations and ongoing improvement initiatives in its medical distribution business.
5 days ago · zacks.com
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You TradeCardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.
13 days ago · zacks.com
Cardinal Health (CAH) Laps the Stock Market: Here's WhyCardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.
18 days ago · zacks.com
3 Low-Beta Defensive Stocks to Buy as Inflation Continues to SurgeAs inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.
20 days ago · zacks.com
Here's Why Cardinal Health (CAH) is a Strong Growth StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
20 days ago · zacks.com
Should Value Investors Buy Cardinal Health (CAH) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
20 days ago · zacks.com
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
27 days ago · zacks.com
Reasons to Retain Cardinal Health Stock in Your Portfolio for NowCAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.
28 days ago · zacks.com
Cardinal Health (CAH) Outperforms Broader Market: What You Need to KnowCardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.
1 month ago · prnewswire.com
Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS HealthDUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CAH